Adding radiotherapy to standard lung cancer treatment extends progression-free survival
A clinical trial involving 140 patients has found that using high-dose radiotherapy alongside standard treatment for advanced lung cancer delays disease progression by an average of five months. This approach offers patients more time without the cancer spreading, providing a clearer path for personalised care in the NHS.
Source: WalesOnline
National
Read the full story